Results 21 to 30 of about 1,695 (109)

TRPM2-AS promotes the malignancy of osteosarcoma cells by targeting miR-15b-5p/PPM1D axis

open access: yes, 2022
Osteosarcoma (OS) is a malignant tumor with a low survival rate and a high incidence rate worldwide. Although research has reported the involvement of long non-coding RNAs (lncRNAs) in the pathogenesis of OS cells, the role of TRPM2-AS, miR-15b-5p, and ...
Yingchun Cai (3809575)   +4 more
core   +1 more source

Function and modulation of TRPM2 channels [PDF]

open access: yes, 2013
Melastatin-related transient receptor potential 2 (TRPM2) channel is a Ca2+-permeable cation channel that is gated by ADP-ribose (ADPR) and also activated by reactive oxygen species (ROS) such as H2O2. TRPM2 channel are shown to be critically involved in
Zou, Jie
core   +4 more sources

TRPM2 ion channels steer neutrophils towards a source of hydrogen peroxide

open access: yes, 2021
Neutrophils must navigate accurately towards pathogens in order to destroy invaders and thus defend our bodies against infection. Here we show that hydrogen peroxide, a potent neutrophil chemoattractant, guides chemotaxis by activating calcium-permeable ...
Chun-Hsiang Tan   +5 more
core   +1 more source

Role of TRPM2 in H(2)O(2)-induced cell apoptosis in endothelial cells. [PDF]

open access: yesPLoS ONE, 2012
Melastatin-like transient receptor potential channel 2 (TRPM2) is an oxidant-sensitive and cationic non-selective channel that is expressed in mammalian vascular endothelium. Here we investigated the functional role of TRPM2 channels in hydrogen peroxide
Lei Sun   +5 more
doaj   +1 more source

The vital role of TRPM2 in breast cancer cell proliferation and its difference in expression between non-Hispanic white and non-Hispanic black females [PDF]

open access: yesWorld Cancer Research Journal
Objective: To study the racial disparity of transient receptor potential melastatin-related channel subtype 2 (TRPM2) expression in non-Hispanic black (NHB) women and non-Hispanic white women (NHW) breast cancer tissues.
L. Huang, Y. Lu, M. Li
doaj   +1 more source

Involvement of TRPM2 in a wide range of inflammatory and neuropathic pain mouse models

open access: yesJournal of Pharmacological Sciences, 2015
Recent evidence suggests a role of transient receptor potential melastatin 2 (TRPM2) in immune and inflammatory responses. We previously reported that TRPM2 deficiency attenuated inflammatory and neuropathic pain in some pain mouse models, including ...
Kanako So   +8 more
doaj   +1 more source

Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancer

open access: yesJournal of Ovarian Research, 2023
Introduction Ovarian cancer (OC) is one of the most common gynecologic malignant cancers with the current survival rate remaining low. TRPM2 has been reported as a survival predictor in various cancers but not in OC.
Wei Huang   +9 more
doaj   +1 more source

TRPM2 promotes pancreatic cancer by PKC/MAPK pathway

open access: yesCell Death and Disease, 2021
The mechanism of pancreatic cancer (PA) is not fully understanded. In our last report, TRPM2 plays a promising role in pancreatic cancer. However, the mechanism of TRPM2 is still unknown in this dismal disease.
Rui Lin   +7 more
doaj   +1 more source

The Janus-faced role of TRPM2-S in retroperitoneal liposarcoma via increasing ROS levels

open access: yesCell Communication and Signaling, 2022
Background Retroperitoneal liposarcoma (RPLS) is a specific soft tissue sarcoma with a high recurrence rate. The short isoform of transient receptor potential cation channel subfamily M member 2 (TRPM2-S) plays an important role in the regulation of ...
Xiangji Li   +7 more
doaj   +1 more source

cADPR Does Not Activate TRPM2

open access: yes, 2022
cADPR is a second messenger that releases Ca2+ from intracellular stores via the ryanodine receptor. Over more than 15 years, it has been controversially discussed whether cADPR also contributes to the activation of the nucleotide-gated cation channel ...
Andreas Bauche   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy